.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
McKesson
AstraZeneca
Cerilliant
Boehringer Ingelheim
Novartis
Colorcon
Baxter
Accenture
Johnson and Johnson

Generated: January 20, 2018

DrugPatentWatch Database Preview

US Patents With Foreign Priority to France Patent: 99 08923

« Back to Dashboard


Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
Lupin AtlantisANTARA (MICRONIZED)fenofibrateCAPSULE;ORAL021695-001Nov 30, 2004ABRXYesNo➤ Subscribe➤ SubscribeTREATING HYPERTRIGLYCERIDEMIAS WITH REDUCTION OF FOOD EFFECT
Lupin AtlantisANTARA (MICRONIZED)fenofibrateCAPSULE;ORAL021695-001Nov 30, 2004ABRXYesNo➤ Subscribe➤ SubscribeTREATING HYPERCHOLESTEROLEMIAS WITH REDUCTION OF FOOD EFFECT
Lupin AtlantisANTARA (MICRONIZED)fenofibrateCAPSULE;ORAL021695-003Nov 30, 2004ABRXYesYes➤ Subscribe➤ SubscribeTREATING HYPERCHOLESTEROLEMIAS WITH REDUCTION OF FOOD EFFECT
Lupin AtlantisANTARA (MICRONIZED)fenofibrateCAPSULE;ORAL021695-003Nov 30, 2004ABRXYesYes➤ Subscribe➤ SubscribeTREATING HYPERTRIGLYCERIDEMIAS WITH REDUCTION OF FOOD EFFECT
Lupin AtlantisANTARA (MICRONIZED)fenofibrateCAPSULE;ORAL021695-001Nov 30, 2004ABRXYesNo➤ Subscribe➤ SubscribeYY
Lupin AtlantisANTARA (MICRONIZED)fenofibrateCAPSULE;ORAL021695-003Nov 30, 2004ABRXYesYes➤ Subscribe➤ SubscribeYY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Table 'thinkbio_newdpw.patent_gazette' doesn't exist